N
← Back to Search
Sponsored

Accelerate Your Clinical Trial Recruitment

Reach thousands of high-intent patients matching your specific inclusion criteria.

Start Campaign
RECRUITING Phase 3 ClinicalTrials.gov

A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy

Sponsor: Janssen Research & Development, LLC • ClinicalTrials.gov ID: NCT06750094

Registry updated: 2026-09-25
Ad

Recruiting for Similar Conditions?

Sponsors are looking for patients like you. See if you qualify for compensated research studies.

Check Eligibility →

Description

The purpose of this study is to compare how long the participants are disease-free (progression-free survival) and and the length of time until a participant dies (overall survival), when treated with amivantamab and chemotherapy with 5-fluorouracil, leucovorin calcium (folinic acid) or levoleucovorin, and irinotecan hydrochloride (FOLFIRI) versus either cetuximab or bevacizumab and FOLFIRI given to participants with Kirsten rat sarcoma viral oncogene/ neuroblastoma RAS viral oncogene homolog (KRAS/ NRAS) and v-raf murine sarcoma viral oncogene homolog B (BRAF) wild-type recurrent, unresectable or metastatic colorectal cancer who have previously received chemotherapy.

Interventions

  • Amivantamab (Biological)
    Amivantamab will be administered.
  • Cetuximab (Biological)
    Cetuximab will be administered.
  • Bevacizumab (Biological)
    Bevacizumab will be administered.
  • 5-fluorouracil (Drug)
    5-fluorouracil will be administered as chemotherapy regimen.
  • Leucovorin calcium/Levoleucovorin (Drug)
    Leucovorin calcium/Levoleucovorin will be administered as chemotherapy regimen.
  • Irinotecan (Drug)
    Irinotecan will be administered as chemotherapy regimen.

Eligibility criteria

Inclusion Criteria: * Have histologically or cytologically confirmed adenocarcinoma of the colon or rectum. Participants must have recurrent, unresectable or metastatic disease * Determined to have kirsten rat sarcoma viral oncogene/neuroblastoma RAS viral oncogene homolog (KRAS/NRAS), G12, G13 and v-raf murine sarcoma viral oncogene homolog B (BRAF) V600X (X represents any single amino acid change from the original amino acid) wild type status by local and/or central next-generation sequencing (NGS) testing * Must agree to the submission of fresh or archival tumor tissue post progression from the most recent therapy, if clinically feasible * Have measurable disease according to response evaluation criteria in solid tumors (RECIST) version (v) 1.1 * Have an eastern cooperative oncology group (ECOG) performance status (PS) of 0 or 1 * Participant must have received 1 line of systemic therapy (fluoropyrimidine-based and oxaliplatin-based) for metastatic colorectal cancer (mCRC), with documented radiographic disease progression on or after this line of therapy. Participants can receive anti-VEGF as prior line of therapy Exclusion Criteria: * Has medical history of (noninfectious) interstitial lung disease (ILD) /pneumonitis/pulmonary fibrosis or has current ILD/pneumonitis/pulmonary fibrosis, or where suspected ILD/pneumonitis/pulmonary fibrosis cannot be ruled out by imaging at screening * Has known allergies, hypersensitivity, or intolerance to excipients of any of the following: amivantamab, cetuximab or bevacizumab or any component of FOLFIRI * Has a prior or concurrent second malignancy other than the disease under study or one whose natural history or treatment is likely to interfere with any study endpoints of safety or the efficacy of the study treatment(s) * Participant with known mismatch repair deficiency (dMMR)/ high microsatellite instability (MSI-H) status who has not received immunotherapy treatments * Participant with known human epidermal growth factor receptor 2 (HER2)- positive/amplified tumor * Has prior exposure to irinotecan, any agents that target epidermal growth factor receptor (EGFR) or mesenchymal epithelial transition (MET)

Conditions

Colorectal Neoplasms

Locations

  • Ironwood Cancer and Research Center — Chandler, Arizona, United States
  • Banner MD Anderson Cancer Center — Gilbert, Arizona, United States
  • Arizona Oncology Associates PC NAHOA — Prescott, Arizona, United States
  • St. Bernard's Medical Center — Jonesboro, Arkansas, United States
  • Highlands Oncology Group — Springdale, Arkansas, United States
  • CBCC Global Research — Bakersfield, California, United States
  • Los Angeles Cancer Network — Glendale, California, United States
  • Cancer and Blood Specialty Clinic — Los Alamitos, California, United States
  • USC Norris Comprehensive Cancer Center — Los Angeles, California, United States
  • UCLA — Santa Monica, California, United States
  • Providence Medical Foundation — Santa Rosa, California, United States
  • Torrance Memorial Physicians Network — Torrance, California, United States
  • University of Colorado Denver Anschultz Medical Campus — Aurora, Colorado, United States
  • Rocky Mountain Cancer Centers — Denver, Colorado, United States
  • Eastern Connecticut Hematology & Oncology Assoc. — Norwich, Connecticut, United States
  • Florida Cancer Specialists South — Fort Myers, Florida, United States
  • Mount Sinai Medical Center Campus — Miami Beach, Florida, United States
  • AdventHealth Cancer Institute — Orlando, Florida, United States
  • Florida Cancer Specialists North Region — St. Petersburg, Florida, United States
  • Florida Cancer Specialists East — West Palm Beach, Florida, United States
  • University Cancer And Blood Center LLC — Athens, Georgia, United States
  • Grady Memorial Hospital — Atlanta, Georgia, United States
  • Piedmont Cancer Institute — Atlanta, Georgia, United States
  • Winship Cancer Institute Emory University — Atlanta, Georgia, United States
  • Illinois Cancer Specialists — Arlington Heights, Illinois, United States
  • Illinois CancerCare — Peoria, Illinois, United States
  • Franciscan Health — Indianapolis, Indiana, United States
  • University of Iowa Hospitals and Clinics — Iowa City, Iowa, United States
  • Mission Cancer Blood — Waukee, Iowa, United States
  • Cancer Center of Kansas — Wichita, Kansas, United States
  • Mary Bird Perkins Cancer Center — Baton Rouge, Louisiana, United States
  • MedStar Franklin Square Medical Center — Baltimore, Maryland, United States
  • Frederick Health Hospital - James M Stockman Cancer Institute — Frederick, Maryland, United States
  • University of Michigan Rogel Cancer Center — Ann Arbor, Michigan, United States
  • Henry Ford Hospital — Detroit, Michigan, United States
  • Cancer And Hematology Centers of Western Michigan PC — Grand Rapids, Michigan, United States
  • Hattiesburg Clinic — Hattiesburg, Mississippi, United States
  • Washington University School Of Medicine — St Louis, Missouri, United States
  • Nebraska Cancer Specialists — Omaha, Nebraska, United States
  • Astera Cancer Care — East Brunswick, New Jersey, United States
  • Perlmutter Cancer Center at NYU Long Island — Mineola, New York, United States
  • NYU Langone Medical Center NYU Hematology Associates — New York, New York, United States
  • New York Cancer and Blood Specialists — Shirley, New York, United States
  • Montefiore Einstein Comprehensive Cancer Center — The Bronx, New York, United States
  • University of Buffalo Kaleida Health Cancer Care — Williamsville, New York, United States
  • Gabrail Cancer Center — Canton, Ohio, United States
  • University Hospital of Cleveland — Cleveland, Ohio, United States
  • Oregon Health And Science University — Portland, Oregon, United States
  • Alliance Cancer Specialists at Main Line — Penn Wynne, Pennsylvania, United States
  • Thomas Jefferson University — Philadelphia, Pennsylvania, United States
  • Fox Chase Cancer Center — Philadelphia, Pennsylvania, United States
  • University Of Pittsburgh Medical Center UPMC Hillman Cancer Center — Pittsburgh, Pennsylvania, United States
  • Tennessee Oncology Chattanooga — Chattanooga, Tennessee, United States
  • SCRI Oncology Partners — Nashville, Tennessee, United States
  • Tennessee Oncology — Nashville, Tennessee, United States
  • Vanderbilt University Medical Center — Nashville, Tennessee, United States
  • Texas Oncology West Texas — Abilene, Texas, United States
  • Parkland Health and Hospital System — Dallas, Texas, United States
  • Texas Oncology DFW — Dallas, Texas, United States
  • UT Southwestern Medical Center — Dallas, Texas, United States
  • MD Anderson Cancer Center — Houston, Texas, United States
  • Baylor Scott & White Medical Center — Round Rock, Texas, United States
  • Texas Oncology - San Antonio — San Antonio, Texas, United States
  • Scott And White Memorial Hospital — Temple, Texas, United States
  • UT Health East Texas HOPE Cancer Center — Tyler, Texas, United States
  • Virginia Cancer Specialists — Arlington, Virginia, United States
  • Richmond VA Medical Center — Richmond, Virginia, United States
  • VCU Massey Comprehensive Cancer Center — Richmond, Virginia, United States
  • Providence Regional Cancer System — Lacey, Washington, United States
  • Fred Hutchinson Cancer Research Center — Seattle, Washington, United States
  • Medical College Of Wisconsin — Milwaukee, Wisconsin, United States
  • Concord Hospital — Concord, Australia
  • Warringal Private Hospital — Heidelberg, Australia
  • Queen Elizabeth Hospital — South Woodville, Australia
  • Western Health Sunshine Hospital — St Albans, Australia
  • Institut Jules Bordet — Anderlecht, Belgium
  • UZ Antwerpen — Edegem, Belgium
  • AZ Maria Middelares — Ghent, Belgium
  • Jolimont — Haine Saint Paul La Louviere, Belgium
  • Az Groeninge — Kortrijk, Belgium
  • Universitair Ziekenhuis Leuven — Leuven, Belgium
  • Centre Hospitalier Universitaire de Liege Domaine Universitaire du Sart Tilman — Liège, Belgium
  • Fundacao Pio XII — Barretos, Brazil
  • Fundacao Universidade de Caxias do Sul — Caxias do Sul, Brazil
  • Fundacao Doutor Amaral Carvalho — Jaú, Brazil
  • Hospital Nossa Senhora da Conceicao S A — Porto Alegre, Brazil
  • Hospital Santa Izabel Santa Casa de Misericordia da Bahia — Salvador, Brazil
  • Funfarme Sjrp — São José do Rio Preto, Brazil
  • Fundacao Faculdade de Medicina - Instituto do Cancer do Estado de Sao Paulo — São Paulo, Brazil
  • Fundacao Antonio Prudente A C Camargo Cancer Center — São Paulo, Brazil
  • Sociedade Beneficente Israelita Brasileira Hospital Albert Einstein — São Paulo, Brazil
  • Associacao Feminina de Educacao e Combate ao Cancer Hospital Santa Rita de Cassia — Vitória, Brazil
  • Peking University First Hospital — Beijing, China
  • Beijing Friendship Hospital Capital Medical University — Beijing, China
  • Beijing Cancer Hospital — Beijing, China
  • The First Bethune Hospital of Jilin University — Changchun, China
  • Hunan Cancer hospital — Changsha, China
  • West China Hospital of Sichuan University — Chengdu, China
  • Ganzhou Cancer Hospital — Ganzhou, China
  • Sun Yat Sen University Cancer Center — Guangzhou, China
  • The Sixth Affiliated Hospital Sun Yat sen University — Guangzhou, China
  • Guangdong Provincial People's Hospital — Guangzhou, China
  • The Second Affiliated Hospital of Zhejiang University — Hangzhou, China
  • Zhejiang Cancer Hospital — Hangzhou, China
  • Harbin medical university cancer hospital — Harbin, China
  • Huizhou Central People's Hospital — Huizhou, China
  • Gansu Provincial Cancer Hospital — Lanzhou, China
  • The First Affiliated Hospital of NanChang University — Nanchang, China
  • Fudan University Shanghai Cancer Center — Shanghai, China
  • Liaoning Cancer Hospital and Institute — Shenyang, China
  • Tianjin Medical University Cancer Institute and Hospital — Tianjin, China
  • Hubei Cancer Hospital — Wuhan, China
  • Institut Sainte Catherine — Avignon, France
  • Hopital Haut Leveque — Pessac, France
  • CHU De Poitiers — Poitiers, France
  • Charite Universitatsmedizin Berlin Campus Virchow Klinikum — Berlin, Germany
  • Krankenhaus NorthWest — Frankfurt am Main, Germany
  • National Center for Tumor Diseases NCT — Heidelberg, Germany
  • Universitatsmedizin der Johannes Gutenberg Universitat Mainz — Mainz, Germany
  • Klinikum der Universitaet Muenchen — Munich, Germany
  • Queen Mary Hospital — Hong Kong, Hong Kong
  • Prince Of Wales Hospital — Shatin, Hong Kong
  • Markhot Ferenc Oktatokorhaz es Rendelointezet — Eger, Hungary
  • Pecsi Tudomanyegyetem — Pécs, Hungary
  • Szegedi Tudomanyegyetem — Szeged, Hungary
  • Rajiv Gandhi Cancer Institute and Research Centre — Delhi, India
  • Asian Institute Of Gastroenterology — Hyderabad, India
  • B P Poddar Hospital and Medical research Limited — Kolkata, India
  • Tata Memorial Hospital — Mumbai, India
  • Safdarjung Hospital — New Delhi, India
  • Deenanath Mangeshkar Hospital and Research Centre — Pune, India
  • Mahamana Pandit Madan Mohan Malviya Cancer Centre — Varanasi, India
  • Christian medical — Vellore, India
  • Yitzhak Shamir Medical Center — Beer Yaakov, Israel
  • Rambam Medical Center — Haifa, Israel
  • Hadassah Medical Center — Jerusalem, Israel
  • Rabin Medical Center — Petah Tikva, Israel
  • Sheba Medical Center — Ramat Gan, Israel
  • Tel Aviv Sourasky Medical Center — Tel Aviv, Israel
  • Assuta MC — Tel Aviv, Israel
  • Fondazione del Piemonte per I Oncologia IRCC Candiolo — Candiolo, Italy
  • ARNAS Garibaldi P O Nesima — Catania, Italy
  • Careggi University Hospital — Florence, Italy
  • Istituto Dei Tumori Di Milano — Milan, Italy
  • Istituto Oncologico Veneto - IRCCS — Padova, Italy
  • Azienda Ospedaliero Universitaria Pisana — Pisa, Italy
  • Istituto Clinico Humanitas — Rozzano, Italy
  • Azienda Sanitaria Universitaria Friuli Centrale ASU FC — Udine, Italy
  • Chiba Cancer Center — Chiba, Japan
  • National Cancer Center Hospital — Chūōku, Japan
  • National Cancer Center Hospital East — Kashiwa, Japan
  • Aichi Cancer Center — Nagoya, Japan
  • National Hospital Organization Osaka National Hospital — Osaka, Japan
  • Osaka International Cancer Institute — Osaka, Japan
  • Kindai University Hospital — Sakai, Japan
  • Shizuoka Cancer Center — Shizuoka, Japan
  • The University of Osaka Hospital — Suita, Japan
  • The Cancer Institute Hospital of JFCR — Tokyo, Japan
  • Hospital Pulau Pinang — George Town, Malaysia
  • Hospital Raja Permaisuri Bainun — Ipoh, Malaysia
  • Hospital Kuala Lumpur — Kuala Lumpur, Malaysia
  • University Malaya Medical Centre — Kuala Lumpur, Malaysia
  • Hospital Umum Sarawak — Kuching, Malaysia
  • Institut Kanser Negara Clinical Research Center — Putrajaya, Malaysia
  • Centro Oncologico de Chihuahua — Chihuahua City, Mexico
  • Actualidad Basada En La Investigacion Del Cancer — Guadalajara, Mexico
  • Centro Oncologico Personalizado Cope S De R L De C V — Mexico City, Mexico
  • Instituto Nacional de Cancerologia — Mexico City, Mexico
  • Hospital Universitario Dr Jose Eleuterio Gonzalez — Monterrey, Mexico
  • Oncocenter — Puebla City, Mexico
  • Cuidados Oncologicos — Querétaro, Mexico
  • Health Pharma Queretaro SA de CV — Querétaro, Mexico
  • COI Centro Oncologico Internacional Tijuana — Tijuana, Mexico
  • Meander Medisch Centrum — Amersfoort, Netherlands
  • Antoni van Leeuwenhoek — Amsterdam, Netherlands
  • Radboud University Medical Center — Nijmegen, Netherlands
  • Erasmus MC — Rotterdam, Netherlands
  • ETZ TweeSteden — Tilburg, Netherlands
  • Bialostockie Centrum Onkologii im Marii Sklodowskiej Curie w Bialymstoku — Bialystok, Poland
  • Wojewodzki Szpital Specjalistyczny — Biała Podlaska, Poland
  • Szpital Specjalistyczny w Brzozowie Podkarpacki Osrodek Onkologiczny im Ks B Markiewicza — Brzozów, Poland
  • Uniwersyteckie Centrum Kliniczne — Gdansk, Poland
  • Narodowy Instytut Onkologii im Marii Sklodowskiej Curie Panstwowy Instytut BadawczyOddz w Gliwicach — Gliwice, Poland
  • Instytut Centrum Zdrowia Matki Polki — Lodz, Poland
  • Szpital Kliniczny MSWiA z WMCO — Olsztyn, Poland
  • SPZOZ Opolskie Centrum Onkologii im. Prof. Tadeusza Koszarowskiego — Opole, Poland
  • Narodowy Instytut Onkologii im Marii Sklodowskiej Curie Panstwowy Instytut Badawczy — Warsaw, Poland
  • Pan American Center for Oncology Trials LLC — San Juan, Puerto Rico
  • Centrul Medical Unirea SRL — Brasov, Romania
  • Spitalul Memorial Baneasa — Bucharest, Romania
  • Ponderas Academic Hospital — Bucharest, Romania
  • Neolife Medical Center Bucharest — Bucharest, Romania
  • Institutul Oncologic 'Prof Dr. Ion Chiricuta' Cluj-Napoca — Cluj-Napoca, Romania
  • Clinica de Oncologie Sf Nectarie — Craiova, Romania
  • Institutul Regional de Oncologie Iasi — Iași, Romania
  • Pelican Impex SRL — Oradea, Romania
  • Kyungpook National University Chilgok Hospital — Daegu, South Korea
  • Korea University Anam Hospital — Seoul, South Korea
  • Seoul National University Hospital — Seoul, South Korea
  • Severance Hospital Yonsei University Health System — Seoul, South Korea
  • Asan Medical Center — Seoul, South Korea
  • Samsung Medical Center — Seoul, South Korea
  • The Catholic University of Korea Seoul St Mary s Hospital — Seoul, South Korea
  • Hosp. Univ. de Badajoz — Badajoz, Spain
  • Hosp. Del Mar — Barcelona, Spain
  • Hosp. Univ. Quiron Dexeus — Barcelona, Spain
  • Hosp Univ Vall D Hebron — Barcelona, Spain
  • Hosp. de La Santa Creu I Sant Pau — Barcelona, Spain
  • Hosp San Francisco de Asis — Madrid, Spain
  • Hosp. Gral. Univ. Gregorio Maranon — Madrid, Spain
  • Hosp. Univ. Ramon Y Cajal — Madrid, Spain
  • Hosp Univ Fund Jimenez Diaz — Madrid, Spain
  • Hosp. Univ. 12 de Octubre — Madrid, Spain
  • Hosp Regional Univ de Malaga — Málaga, Spain
  • Clinica Univ. de Navarra — Pamplona, Spain
  • Hosp. Virgen Del Rocio — Seville, Spain
  • Hosp. Clinico Univ. de Valencia — Valencia, Spain
  • Sahlgrenska Universitetssjukhuset — Gothenburg, Sweden
  • Skanes universitetssjukhus — Lund, Sweden
  • Sodersjukhuset — Stockholm, Sweden
  • Karolinska Universitetssjukhuset — Stockholm, Sweden
  • Uppsala University — Uppsala, Sweden
  • Kaohsiung Medical University Chung Ho Memorial Hospital — Kaohsiung City, Taiwan
  • Chang Gung Memorial Hospital — Kaohsiung City, Taiwan
  • Taichung Veterans General Hospital — Taichung, Taiwan
  • National Cheng Kung University Hospital — Tainan, Taiwan
  • National Taiwan University Hospital — Taipei, Taiwan
  • Taipei Veterans General Hospital — Taipei, Taiwan
  • Linkou Chang Gung Memorial Hospital — Taoyuan, Taiwan
  • Ramathibodi Hospital — Bangkok, Thailand
  • Siriraj Hospital — Bangkok, Thailand
  • Chiang Mai University — Chiang Mai, Thailand
  • Songklanagarind hospital — Songkhla, Thailand
  • Adana City Hospital — Adana, Turkey (Türkiye)
  • Gulhane Egitim ve Arastirma Hastanesi — Ankara, Turkey (Türkiye)
  • Dr Abdurrahman Yurtaslan Oncology Training and Research Hospital — Ankara, Turkey (Türkiye)
  • Gazi Universitesi Hastanesi — Ankara, Turkey (Türkiye)
  • Ankara Bilkent Sehir Hastanesi — Ankara, Turkey (Türkiye)
  • Memorial Antalya Hospital — Antalya, Turkey (Türkiye)
  • Trakya University Medical Faculty — Edirne, Turkey (Türkiye)
  • Bakirkoy Training and Research Hospital — Istanbul, Turkey (Türkiye)
  • Marmara Universitesi Pendik Egitim ve Arastirma Hastanesi — Istanbul, Turkey (Türkiye)
  • Necmettin Erbakan Universitesi Tip Fakultesi Hastanesi — Konya, Turkey (Türkiye)
  • Sakarya University Training and Research Hospital — Sakarya, Turkey (Türkiye)
  • Birmingham Heartlands Hospital — Birmingham, United Kingdom
  • Castle Hill Hospital — Hull, United Kingdom
  • St James University Hospital — Leeds, United Kingdom
  • St Bartholomew's Hospital — London, United Kingdom
  • University College Hospital — London, United Kingdom
  • Royal Marsden Hospital — London, United Kingdom
  • Mount Vernon Cancer Centre — Northwood, United Kingdom
Sponsored

Partner with Nurenyx

Showcase your study to thousands of motivated patients matching your criteria.

Learn More

Official Source

Data sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

View Official Record